Generex Biotechnology Ae37 cancer vaccine

hi, this is a Bloomberg West innovators segment aired on the 20 dec 2011. It reports on the ongoing phase II trial of antigen express’s ae37 cancer vaccine, after strong results posted at the Sabcs 2011 a week ago…… antigen express in owned by Generex biotechnology better days 🙂
Video Rating: 5 / 5

Leave a Reply